
Lyka Labs Ltd is Rated Strong Sell
2026-04-04 10:10:13Lyka Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 January 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 04 April 2026, providing investors with the latest comprehensive view of the company’s position.
Read full news article
Markets Rally, But Lyka Labs Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-30 09:50:41Despite a broader market recovery, Lyka Labs Ltd has plunged to a fresh 52-week low of Rs 44.55 on 30 Mar 2026, marking a steep 53.37% decline over the past year and underscoring persistent headwinds for this micro-cap pharmaceutical player.
Read full news article
Markets Rally, But Lyka Labs Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-27 12:26:38While broader indices showed signs of recovery, Lyka Labs Ltd plunged to a fresh 52-week low of Rs 47.3 on 27 Mar 2026, marking a steep decline of 7.74% intraday and underperforming its sector by over 7%. This drop extends the stock’s downward trajectory amid persistent financial headwinds and market scepticism.
Read full news article
Markets Rally, But Lyka Labs Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-24 15:40:14Despite a broadly positive market environment, Lyka Labs Ltd has plunged to a fresh 52-week low of Rs 47.7 on 24 Mar 2026, extending its recent downward trajectory amid persistent headwinds.
Read full news article
Lyka Labs Ltd is Rated Strong Sell
2026-03-24 10:10:16Lyka Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Lyka Labs Ltd Stock Hits 52-Week Low Amidst Continued Downtrend
2026-03-17 11:45:33Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.51.17 on 17 Mar 2026, marking a significant decline amid persistent underperformance and deteriorating financial metrics.
Read full news article
Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.51.45
2026-03-16 10:11:33Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.51.45 today, marking a significant decline in its stock price amid ongoing financial and market pressures. This fresh low underscores the stock’s persistent underperformance relative to its sector and benchmark indices.
Read full news article
Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.54 Amid Continued Downtrend
2026-03-13 09:42:58Lyka Labs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.54 today, marking a significant decline amid ongoing market pressures and company-specific headwinds. The stock has underperformed its sector and benchmark indices, reflecting persistent challenges in its financial and technical performance.
Read full news articleBoard Meeting Outcome for Outcome Of The Board Meeting Held On 31St March 2026
31-Mar-2026 | Source : BSEAs per the letter attached
Closure of Trading Window
27-Mar-2026 | Source : BSEClosure of Trading Window
Board Meeting Intimation for Prior Intimation Of Board Meeeting
23-Mar-2026 | Source : BSELyka Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/03/2026 inter alia to consider and approve As per the letter attached
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available







